Primary Biliary Cholangitis
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the immune system gradually destroys the small bile ducts inside the liver. Bile backs up, causing inflammation and, over years, scarring.
Key takeaways
- Ursodeoxycholic acid is commonly used to improve bile flow; biochemical response and disease stage guide follow-up and additional treatment.
- Diagnosis and follow-up use liver blood tests, relevant antibodies and assessment for fibrosis, symptoms and treatment response.
- There is no cure, but treatment can significantly slow liver damage and reduce symptoms such as fatigue and itching.
The listings below do not confirm primary biliary cholangitis; diagnosis and treatment response depend on liver tests, antibodies, imaging and specialist follow-up.
Slowing the progression of primary biliary cholangitis
When started early and taken consistently, it lowers liver enzyme levels and, in many patients, delays progression to cirrhosis. PBC sits within the broader field of digestive health care. Regular monitoring through blood tests (liver enzymes, bilirubin) and periodic imaging remains essential, as response to treatment guides long-term management. Anyone experiencing unexplained itching, right-side abdominal discomfort, or persistent fatigue should discuss liver function testing with a doctor.
When to seek urgent care
Seek urgent care for vomiting blood, black stools, new confusion, marked drowsiness, rapidly increasing abdominal swelling, fever with abdominal pain or sudden worsening jaundice. These may indicate complications of advanced liver disease or infection.